Last $3.82 USD
Change Today +0.1669 / 4.57%
Volume 26.5K
As of 8:04 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Snapshot

Open
$3.62
Previous Close
$3.65
Day High
$3.95
Day Low
$3.62
52 Week High
06/2/14 - $5.00
52 Week Low
12/5/13 - $1.94
Market Cap
68.4M
Average Volume 10 Days
17.9K
EPS TTM
$-0.37
Shares Outstanding
17.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BOVIE MEDICAL CORP (BVX)

Related News

No related news articles were found.

bovie medical corp (BVX) Related Businessweek News

No Related Businessweek News Found

bovie medical corp (BVX) Details

Bovie Medical Corporation, an energy-based medical device company, develops, manufactures, and markets a range of electrosurgical products and technologies, and related medical products worldwide. The company’s electrosurgery products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers battery operated cauteries; and battery operated medical lights for use in ophthalmology, as well as for general surgery, hip replacement surgery, and the placement of endotracheal tubes in emergency and surgical procedures. In addition, the company manufactures physicians’ office use penlights; and a nerve locator stimulator used for identifying motor nerves in hand and facial reconstructive surgery. Further, Bovie Medical Corporation is developing Derm 101 and Derm 102 products, which are 10 watt high frequency desiccators for use in family practice, aesthetics, and dermatology settings; and Seal-N-Cut, a disposable endoscopic surgical handle. The company markets its products through medical distributors to hospitals, doctor’s offices, and other healthcare facilities. Bovie Medical Corporation was founded in 1982 and is based in Clearwater, Florida.

136 Employees
Last Reported Date: 05/8/14
Founded in 1982

bovie medical corp (BVX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $56.7K
President, Chief Sales & Marketing Officer an...
Total Annual Compensation: $305.2K
Executive Chairman
Total Annual Compensation: $215.5K
Senior Vice President
Total Annual Compensation: $204.8K
Vice President of Sales & Marketing - Surgica...
Total Annual Compensation: $160.1K
Compensation as of Fiscal Year 2013.

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Settlement Agreement for the Stockholder Derivative Action Against the Company

On June 26, 2014, Bovie Medical Corporation entered into a Stipulation and Agreement of Settlement setting forth the terms of the settlement of the claims asserted against the Company and the individual defendants in the previously disclosed stockholder derivative action entitled Arbit, et al v. Makrides, et al pending in the United States District Court for the Middle District of Florida, Tampa Division. The Settlement Agreement remains subject to court approval, and requires the Company to make and/or codify certain corporate governance changes as more specifically described therein. In addition, counsel for the plaintiffs will be entitled to request that the court award of attorney's fees and expenses of up to $850,000, subject to court approval, which amount would be fully funded by insurance proceeds.

Bovie Medical Corporation Hires Jay D. Ewers as Controller

Bovie Medical Corporation announced that it has hired Jay D. Ewers as Controller, effective June 23, 2014. Mr. Ewers comes to Bovie with more than 30 years of senior experience in all phases of finance, accounting, administrative and general management.

Bovie Medical Corporation Announces Executive Changes

Bovie Medical announced the appointment of Peter Donato as Executive Vice President and Chief Financial Officer. Donato has over 22 years of financial management and accounting experience in roles of increasing responsibility. For the past 10 years, he has been focused on healthcare companies. Most recently, he served as Corporate Controller for Cyberonics Inc. Prior to that, Donato served as a CFO for Catasys Inc., and before that, as CFO for IRIS International. Additionally, Bovie Medical announced that Gary Pickett has decided to leave the company, effective June 18, to pursue other opportunities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $3.82 USD +0.1669

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $44.26 USD +0.70
Synergetics USA Inc $3.00 USD +0.02
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.6x
Price/Book 6.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit www.boviemedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.